vimarsana.com

Latest Breaking News On - Pharmaceutical industry and stock news - Page 1 : vimarsana.com

Halozyme Therapeutics Scores RS Rating Jump To 91

On Friday, Halozyme Therapeutics stock earned an upgrade to its Relative Strength (RS) Rating, from 80 to 91.

San-diego
California
United-states
Halozyme-therapeutics
Relative-strength
Halozyme-therapeutics-stock
United-therapeutics
Pharmaceutical-industry-and-stock-news

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72

PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine-biosciences
Alpine-immune-sciences
Relative-strength
Halozyme-therapeutics
Pharmaceutical-industry-and-stock-news

Sarepta Therapeutics Stock Shows Improved Technical Strength

Sarepta Therapeutics Stock Shows Improved Technical Strength
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Cambridge
Cambridgeshire
United-kingdom
Neurocrine-biosciences
Alpine-immune-sciences
Relative-strength
Sarepta-therapeutics
Sarepta-therapeutics-stock
Halozyme-therapeutics
Pharmaceutical-industry-and-stock-news

Amgen Stock Sees Relative Strength Rating Improve To 74

Amgen Stock Sees Relative Strength Rating Improve To 74
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine-biosciences
Amgen
Catalyst-pharmaceuticals
Relative-strength
Amgen-stock
Pharmaceutical-industry-and-stock-news

Ultragenyx Pharm Stock Hits 80-Plus Relative Strength Rating Benchmark

Ultragenyx Pharm Stock Hits 80-Plus Relative Strength Rating Benchmark
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Neurocrine-biosciences
Ultragenyx-pharm
Catalyst-pharmaceuticals
Relative-strength
Ultragenyx-pharm-stock
For-the-next-big-stock-market
Start-with-these
Pharmaceutical-industry-and-stock-news
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.